Breast Cancer and SARS-Cov2: Lessons from a Pandemic
暂无分享,去创建一个
[1] N. Ahmadiyeh,et al. Impact of COVID-19 Restrictions on Stage of Breast Cancer at Presentation and Time to Treatment at an Urban Safety-Net Hospital , 2022, Annals of Surgical Oncology.
[2] P. Boffetta,et al. Global Association of COVID-19 Pandemic Measures With Cancer Screening: A Systematic Review and Meta-analysis. , 2022, JAMA oncology.
[3] J. Boughey,et al. Impact of the COVID-19 Pandemic on Breast Cancer Stage at Diagnosis, Presentation, and Patient Management , 2021, Annals of Surgical Oncology.
[4] M. Piccart,et al. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study , 2021, The Lancet. Oncology.
[5] C. Vincelet,et al. Dépistage du cancer du sein dans deux régions françaises dans le contexte de la crise sanitaire liée à la Covid-19 , 2021, Imagerie de la Femme.
[6] C. Nickson,et al. The impact of the Covid-19 pandemic on breast cancer early detection and screening , 2021, Preventive Medicine.
[7] T. Conroy,et al. Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France , 2021, ESMO Open.
[8] Ž. Bajić,et al. COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study , 2021, The oncologist.
[9] I. Bleiweiss,et al. Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 Pandemic , 2021, JCO oncology practice.
[10] T. Gathani,et al. The COVID-19 pandemic and impact on breast cancer diagnoses: what happened in England in the first half of 2020 , 2020, British Journal of Cancer.
[11] R. Warburton,et al. COVID-19 and breast cancer at a Regional Breast Centre: our flexible approach during the pandemic , 2020, Breast Cancer Research and Treatment.
[12] A. Chiaravalloti,et al. Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario , 2020, In Vivo.
[13] E. Papautsky,et al. Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic , 2020, Breast Cancer Research and Treatment.
[14] A. Purushotham,et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study , 2020, The Lancet Oncology.
[15] Jennifer L. Baker,et al. Taking a Second Look at Neoadjuvant Endocrine Therapy for the Treatment of Early Stage Estrogen Receptor Positive Breast Cancer During the COVID-19 Outbreak. , 2020, Annals of surgery.
[16] C. Balleyguier,et al. [Breast cancer screening and diagnosis at the end of the COVID-19 confinement period, practical aspects and prioritization rules: recommendations of 6 French health professionals societies]. , 2020, Bulletin du cancer.
[17] R. Rouzier,et al. [Impact of the COVID-19 epidemic on requests for initial care for breast cancer]. , 2020, Bulletin du cancer.
[18] M. Santillana,et al. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak , 2020, Cancer discovery.
[19] W. Gradishar,et al. Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium , 2020, Breast Cancer Research and Treatment.
[20] H. Miyashita,et al. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City , 2020, Annals of Oncology.
[21] C. Eastin,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The Journal of Emergency Medicine.
[22] Li Zhang,et al. Risk of COVID-19 for patients with cancer , 2020, The Lancet Oncology.
[23] Ruchong Chen,et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China , 2020, The Lancet Oncology.
[24] J. Beck,et al. Time to Surgery and Breast Cancer Survival in the United States. , 2016, JAMA oncology.